The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Here is Norths post from yesterday . At a guess i would say Belgium in Europe , as ORPH already have strong links there, and a subsidiary.
"https://www.google.co.uk/amp/s/uk.news.yahoo.com/amphtml/the-uk-launches-worlds-first-human-challenge-trial-for-covid-19-with-irish-company-h-vivo-063000119.html
**Last paragraph of the news report below**
Cathal Friel, hVivo’s executive chairperson, told Yahoo Finance that in addition to the U.K. launch, the company is also in final stages for establishing a quarantine center in Australia, and “shortly thereafter, in North America.” But where on the continent has yet to be revealed. In both cases, hVivo would be partnering, rather than running, the trials. Go on Cathal!
Unfortunate that the guy has died but theres absolutely no link to ORPH, id even say it would make our services more appealing to prevent stuff like this happening , a lot of these pharmas are rushing things, theres a reason why ORPH wont be ready to start the trials until next year, because the science to get the setup/model right takes time.
To say people are spooked and selling because of that is like reading that FORD had a problem in one of its cars and dumping all of your shares in Aston Martin, hard to believe but there may be a few with deep pockets who dont research
Thanks north, that is massive news! Why is there not more buzz about that?
Read my previous post from yesterday Markshares
The volunteer did not take the vaccine, he had a placebo. That means he was given nothing but the idea that it was the vaccine.
https://www.bloomberg.com/news/articles/2020-10-21/astrazeneca-dips-on-report-of-brazil-death-in-vaccine-trial
Jimi, what's this about Aus and US franchise?
not all people who investst or trade, research - they just have too much spare cash !
light touchpaper and stand well back - when was the last time we dropped 8% in a day ? ofcourse there are profit takers, sellers - but I can assure you, that folk that jumped on the band wagon after the Gov Contract announcement - who haven't researched or understand this business would have been spooked and jumped
Garbage, the poor bloke who died has nothing whatsoever to do with this drop, complete kak.
the reaction to the unfortunate death of someone in Brazil has somewhat effected this share price - the sell off by those who have never performed a single piece of research is gauling - this share unlitimately is going north !
If your looking to sell a company, the kicker is the brand.
This week, the brand has been established - thats the intangible significance of this weeks RNS [along with US and Aus franchise]
4D intention to merge and proposed listing on Nasdaq. I wonder if we get an RNS like that in the future regarding Imutex. Personally I think CF will sell and divi to PI's. ICON love to accumulate bio techs. Let's hope we are on their radar and they reach into their very deep pockets for us.